Newbury Pharmaceuticals AB (NEWBRY) — Free Cash Flow Generation Index
Latest as of February 2026:
1.00x
Newbury Pharmaceuticals AB (NEWBRY) has a Free Cash Flow Generation Index of 1.00x as of February 2026. Free cash flow of Skr2.26 Million represents 1% of operating cash flow (Skr2.26 Million). Check Newbury Pharmaceuticals AB tangible net worth ratio to evaluate the tangible quality of the company's equity base.
FCF Generation Index
1.00x
Free Cash Flow / Operating CF
Free Cash Flow
Skr2.26 Million
SEK
Operating Cash Flow
Skr2.26 Million
SEK
Capital Expenditures
Skr0.00
SEK
Annual Free Cash Flow Generation for Newbury Pharmaceuticals AB (None–None)
Year-by-year Free Cash Flow Generation Index for Newbury Pharmaceuticals AB. Check Newbury Pharmaceuticals AB total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (SEK) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).